Funder: National Institutes of Health
Due Dates: May 25, 2025 | September 25, 2025 | January 25, 2026 | May 25, 2026 | September 25, 2026
Funding Amounts: Up to $1,515,000 in direct costs per year (or $1,765,000 if including an ESI-led project with ≥4 projects); maximum project period 5 years.
Summary: Supports multi-project, collaborative research on heart, lung, blood, and sleep diseases, including implementation science and health disparities, with a focus on integrated, innovative programs addressing a central NHLBI mission theme.
Key Information: Applicants requesting ≥$500,000/year in direct costs must contact NHLBI at least 6 weeks before submission; clinical trials are optional but Phase III/IV trials are not allowed.